Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
2017
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature
2008
Platelet activation, coagulation activation and C‐reactive protein in simultaneous samples from the vascular access and peripheral veins of haemodialysis patients
2011
Venous thromboembolism syndrome in gynecological cancer
2006
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
Prevention of VTE in Nonsurgical Patients
2012 Standout
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
2016
Age-related macular degeneration
2018 Standout
Prevention of Venous Thromboembolism
2004 Standout
Fadiga relacionada ao câncer: uma revisão
2011 Standout
Prevention of Venous Thromboembolism
2008 Standout
Chemotherapy-induced thrombosis
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Erythropoietin or darbepoetin for patients with cancer
2012
Works of Ján Staško being referenced
Circulating vascular endothelial growth factor in the normo- and/or microalbuminuric patients with type 2 diabetes mellitus
2009
Erythropoietin and granulocyte colony-stimulating factor increase plasminogen activator inhibitor-1 release in HUVEC culture
2002
Recombinant Activated Factor VII in Patients at High Risk of Bleeding
2004
Soluble P-Selectin During a Single Hemodialysis Session in Patients With Chronic Renal Failure and Erythropoietin Treatment
2007
Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
2009
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences
2016